Neoplasms, Adipose Tissue: Clinical Trials

226 trials for Neoplasms, Adipose Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

103 completed, 39 recruiting, 22 unknown, 21 terminated. 112 Phase 2, 65 Phase 1, 24 Phase 3, 18 Not applicable, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2112Completed 53, Recruiting 18, Unknown 13, Active not recruiting 11, Terminated 8, Withdrawn 6, Not yet recruiting 3
Phase 165Completed 21, Recruiting 19, Terminated 9, Active not recruiting 6, Unknown 5, Withdrawn 3, Not yet recruiting 2
Phase 324Completed 16, Recruiting 3, Terminated 2, Unknown 2, Withdrawn 1
Not applicable18Completed 9, Recruiting 3, Active not recruiting 2, Not yet recruiting 2, Unknown 1, Withdrawn 1
Phase 44Completed 4
Early Phase 13Terminated 2, Recruiting 1

Follow Neoplasms, Adipose Tissue: new trials by email Literature Review of Neoplasms, Adipose Tissue trials Research Report on Neoplasms, Adipose Tissue

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma
DT-7012, Doxorubicin - Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS)
Phase 2Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris802027-02-012026-09-15
Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers
Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Biopsy Procedure, Biospecimen Collection - Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma
Phase 2Not yet recruitingNational Cancer Institute (NCI)422026-11-232026-09-25
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
Lifileucel - Sarcoma, Soft Tissue Sarcoma (STS)
Phase 2RecruitingIovance Biotherapeutics, Inc.802026-10-022026-10-09
Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas
CUSA Minimally Invasive Resection - Lipoma
Not applicableNot yet recruitingChinese PLA General Hospital302026-10-012026-09-01
Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
Cushing s Syndrome, Cushing Disease
RecruitingAzienda Ospedaliero-Universitaria di Modena20002026-07-092026-11-09
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Biospecimen Collection, Computed Tomography, Leukapheresis - Myxoid Liposarcoma, Round Cell Liposarcoma
Early Phase 1RecruitingSeth Pollack82026-04-132026-08-27
Superselective Renal Artery Embolization for Renal Angiomyolipoma
Selective endovascular embolization of kidney artery - Selective Endovascular Embolization of Kidney Artery
Active not recruitingBotkin Hospital502026-04-062026-04-20
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Hepatocellular Carcinoma
Phase 1Not yet recruitingSeattle Children's Hospital212026-04-012025-11-04
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Abemaciclib, Biopsy Procedure, Biospecimen Collection - Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)742026-03-182026-10-21
Radiological Diagnosis of Pediatric Neck Swellings
Lipoma, Branchial Cleft Anomalies
Active not recruitingSohag University502026-02-202026-07-30
Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Definitive radiotherapy - Soft Tissue Sarcoma (STS), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital402026-01-262026-01-28
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
preoperative, Quality of life, Functional outcome - Soft Tissue Sarcoma (Excluding GIST), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital1102026-01-262026-01-28
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Liver Cell Carcinoma
Phase 1RecruitingSeattle Children's Hospital212025-12-222026-02-17
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Pembrolizumab - Sarcoma
Phase 2RecruitingMemorial Sloan Kettering Cancer Center322025-12-042026-07-28
Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma
Ronkyla Plus, Placebo, Kybella - Lipoma, Submental Fullness
Phase 1RecruitingGlonova Pharma Co., Ltd562025-11-142026-10-02
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
Lymphodepletion, TCR-T cells (MDG1015) - Epithelial Ovarian Cancer, Gastro-esophageal Junction Cancer
Phase 1Not yet recruitingMedigene AG552025-07-012024-12-27
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
SA53-OS (phase 1), SA53-OS (phase 2) - Solid Tumor
Phase 1 / Phase 2RecruitingLamassu Bio Inc552025-06-162026-11-09
Optimizing the Timing for Facial Surgical Dressing Removal
sterile gauze dressing - Nevus, Seborrheic Keratosis (SK)
Not applicableCompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1442025-06-152026-03-03
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Nevus, Seborrheic Keratosis (SK)
CompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1732025-06-152026-02-03
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
21.15.GPC3-CAR T cells - Hepatoblastoma, Hepatocellular Carcinoma
Phase 1RecruitingBaylor College of Medicine212025-06-102025-11-03

Showing 20 of 226. Sign in to see all of them.

Narrower conditions

Liposarcoma (158)  ·  Sarcoma (117)  ·  Leiomyosarcoma (82)  ·  Sarcoma, Synovial (68)  ·  Histiocytoma, Malignant Fibrous (56)  ·  Fibrosarcoma (52)  ·  Hemangiosarcoma (49)  ·  Liposarcoma, Myxoid (40)  ·  Neurofibrosarcoma (40)  ·  Rhabdomyosarcoma (36)  ·  Dermatofibrosarcoma (23)  ·  Hemangiopericytoma, Malignant (22)  ·  Malignant mesenchymal tumor (21)  ·  Osteosarcoma (20)  ·  Sarcoma, Alveolar Soft Part (20)

Broader conditions

Neoplasms by Histologic Type (226)  ·  Neoplasms, Connective and Soft Tissue (225)  ·  Neoplasms (208)  ·  Neoplasms, Connective Tissue (106)  ·  Neoplasms, Muscle Tissue (95)  ·  Neoplasms, Fibrous Tissue (75)  ·  Sarcoma (73)  ·  Neoplasms, Nerve Tissue (62)  ·  Histiocytoma (56)  ·  Nervous System Diseases (53)  ·  Neoplasms, Vascular Tissue (51)  ·  Neoplasms by Site (49)  ·  Nervous System Neoplasms (43)  ·  Neuromuscular Diseases (41)

Interventions

Doxorubicin (26)  ·  Cyclophosphamide (16)  ·  Radiotherapy (16)  ·  Ifosfamide (14)  ·  Trabectedin (11)  ·  Biopsy (7)  ·  Magnetic Resonance Spectroscopy (7)  ·  Specimen Handling (7)  ·  fludarabine (7)  ·  pembrolizumab (7)  ·  pazopanib (6)  ·  Everolimus (5)  ·  Gemcitabine (5)  ·  Radiation (5)  ·  ribociclib (5)

Sponsors

National Cancer Institute (NCI) (16)  ·  European Organisation for Research and Treatment of Cancer - EORTC (15)  ·  Memorial Sloan Kettering Cancer Center (9)  ·  Fred Hutchinson Cancer Center (6)  ·  Novartis Pharmaceuticals (6)  ·  Dana-Farber Cancer Institute (5)  ·  M.D. Anderson Cancer Center (5)  ·  Baylor College of Medicine (4)  ·  Children's Oncology Group (4)  ·  USWM CT, LLC (4)  ·  Adaptimmune (3)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Boehringer Ingelheim (3)  ·  Fudan University (3)  ·  Maria Sklodowska-Curie National Research Institute of Oncology (3)

Countries

United States (136)  ·  France (34)  ·  Canada (30)  ·  United Kingdom (29)  ·  Germany (24)  ·  Netherlands (23)  ·  Spain (21)  ·  Belgium (18)  ·  Italy (17)  ·  China (13)  ·  Denmark (13)  ·  Australia (12)  ·  Poland (10)  ·  Sweden (10)  ·  Taiwan (8)

Top investigators

Seth Pollack (5)  ·  Adaptimmune Patient Enquiries (3)  ·  David Steffin, MD (3)  ·  George D. Demetri, MD (3)  ·  Sandra D'Angelo, MD (3)  ·  Benjamin Izar, MD (2)  ·  Ivar Hompland, MD, PhD (2)  ·  Kjetil Boye, MD, PhD (2)  ·  Lara E Davis (2)  ·  Margaret von Mehren, MD (2)  ·  Mark Dickson, MD (2)  ·  Neeta Somaiah (2)

Results publications

PMID 32827353, PMID 31401903, PMID 19451433, PMID 32002290, PMID 32269142, PMID 10097144, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15177491, PMID 15592836, PMID 15659504, PMID 16528479, PMID 17095209, PMID 17109446, PMID 17336054, PMID 17634494, PMID 19088049, PMID 19451429, PMID 20338746, PMID 20434400, PMID 20471824, PMID 20932656, PMID 21642514, PMID 21915260, PMID 22067397, PMID 22665534, PMID 22954508, PMID 23140536, PMID 23382028, PMID 23437092, PMID 23569312, PMID 23640206, PMID 24215845, PMID 24618336, PMID 24747207, PMID 25258541, PMID 25591040, PMID 25684695, PMID 25858498, PMID 26041763, PMID 26121453, PMID 26156073, PMID 27124835, PMID 27479926, PMID 27502708, PMID 28391003, PMID 28447475, PMID 29023494

NIH funding

P30CA015704 (6), P30CA006516 (4), U10CA098543 (4), UM1CA186709 (3), 2015 (2), 2019 (2), K23CA175167 (2), P30CA008748 (2), P30CA016672 (2), P30CA060553 (2), U10CA180821 (2), U10CA180886 (2), 2004 (1), 2008 (1), 2023 (1)